ES2072883T3 - Inmunoensayo de una etapa para la determinacion de anticuerpos especificos de antigenos de todas las clases de inmunoglobulinas y agente adecuado para ello. - Google Patents

Inmunoensayo de una etapa para la determinacion de anticuerpos especificos de antigenos de todas las clases de inmunoglobulinas y agente adecuado para ello.

Info

Publication number
ES2072883T3
ES2072883T3 ES89120156T ES89120156T ES2072883T3 ES 2072883 T3 ES2072883 T3 ES 2072883T3 ES 89120156 T ES89120156 T ES 89120156T ES 89120156 T ES89120156 T ES 89120156T ES 2072883 T3 ES2072883 T3 ES 2072883T3
Authority
ES
Spain
Prior art keywords
classes
immunoglobulins
determination
stage
specific antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89120156T
Other languages
English (en)
Inventor
Udo Dr Krupka
Hans Erwin Dr Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6366574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2072883(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2072883T3 publication Critical patent/ES2072883T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5762—Hepatitis B core antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V10/00—Arrangements for image or video recognition or understanding
    • G06V10/70—Arrangements for image or video recognition or understanding using pattern recognition or machine learning
    • G06V10/77—Processing image or video features in feature spaces; using data integration or data reduction, e.g. principal component analysis [PCA] or independent component analysis [ICA] or self-organising maps [SOM]; Blind source separation
    • G06V10/80—Fusion, i.e. combining data from various sources at the sensor level, preprocessing level, feature extraction level or classification level
    • G06V10/806—Fusion, i.e. combining data from various sources at the sensor level, preprocessing level, feature extraction level or classification level of extracted features

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Virology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Computing Systems (AREA)
  • Artificial Intelligence (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Computation (AREA)
  • Multimedia (AREA)
  • Software Systems (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE TRATA DE UN PROCEDIMIENTO PARA FABRICAR UN PRODUCTO CON EL CUAL SE REALIZA UN TEST DE UNA SOLA FASE APTO PARA DETERMINAR LOS ANTICUERPOS ESPECIFICOS ANTIGENOS DE TODAS CLASES DE INMUNOGLOBULINA. EN EL TEST INMUNOLOGICO REFERIDO SE INCUBAN LOS ANTIGENOS UNIDOS EN EL PORTADOR (FASE SOLIDA), Y LOS ANTIGENOS SEPARADOS DE LA MISMA ESPECIE, EN UNA DETERMINADA RELACION, EN EL PROCEDIMIENTO, PARA PRODUCIR UNA DETERMINADA RELACION SIMULTANEA CON LA PRUEBA LIQUIDA, QUE CONTIENE ANTICUERPOS. TRAS LA SEPARACION DE LA FASE FLUIDA DE LA FASE SOLIDA, SE DETERMINA LA SEÑALIZACION EN LA FASE SOLIDA.
ES89120156T 1988-11-05 1989-10-31 Inmunoensayo de una etapa para la determinacion de anticuerpos especificos de antigenos de todas las clases de inmunoglobulinas y agente adecuado para ello. Expired - Lifetime ES2072883T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3837616A DE3837616A1 (de) 1988-11-05 1988-11-05 Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aller immunglobulin-klassen und dazu geeignetes mittel

Publications (1)

Publication Number Publication Date
ES2072883T3 true ES2072883T3 (es) 1995-08-01

Family

ID=6366574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89120156T Expired - Lifetime ES2072883T3 (es) 1988-11-05 1989-10-31 Inmunoensayo de una etapa para la determinacion de anticuerpos especificos de antigenos de todas las clases de inmunoglobulinas y agente adecuado para ello.

Country Status (7)

Country Link
EP (1) EP0372217B1 (es)
JP (1) JP2972241B2 (es)
AT (1) ATE122150T1 (es)
AU (1) AU624650B2 (es)
CA (1) CA2002220A1 (es)
DE (2) DE3837616A1 (es)
ES (1) ES2072883T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90800C (fi) * 1991-03-13 1994-03-25 Veikko Naentoe Biospesifinen määritysmenetelmä sekä tuote määritystä varten
CA2064953A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins
AT400640B (de) * 1994-04-26 1996-02-26 Waldheim Pharmazeutika Gmbh Verfahren zum nachweis eines antikörpers
CN1300587C (zh) * 2004-12-20 2007-02-14 山东省医药生物技术研究中心 检测血液脑脊液病原体抗体的蛋白芯片及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
EP0111762B1 (en) * 1980-06-20 1987-11-19 Unilever Plc Processes and apparatus for carrying out specific binding assays
ES511156A0 (es) * 1981-04-13 1983-08-01 Hoechst Co American Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
CA1261740A (en) * 1984-07-16 1989-09-26 Robin A. Gutierrez Immunoassay for detection of common determinant antibody to hepatitis b
NZ222465A (en) * 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
GB8707839D0 (en) * 1987-04-02 1987-05-07 Secr Social Service Brit Immunoglobulin assay method
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel

Also Published As

Publication number Publication date
DE3837616A1 (de) 1990-05-10
EP0372217A3 (de) 1991-10-23
AU4436989A (en) 1990-05-10
JP2972241B2 (ja) 1999-11-08
JPH02171655A (ja) 1990-07-03
ATE122150T1 (de) 1995-05-15
DE58909219D1 (de) 1995-06-08
EP0372217A2 (de) 1990-06-13
AU624650B2 (en) 1992-06-18
EP0372217B1 (de) 1995-05-03
CA2002220A1 (en) 1990-05-05

Similar Documents

Publication Publication Date Title
AU532303B2 (en) Determination of immuno-complexes in liquids
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
DE3579841D1 (de) Multisites immunometrisches testverfahren.
NO172264C (no) Immunokjemisk ettrinns-fremgangsmaate for bestemmelse av et av immunoglobulinantistoffene a, m, d eller e samt reagens for utfoerelse av fremgangsmaate
ATE441111T1 (de) Metallchelat-markierte peptide
JPS6428560A (en) Immunometric measurement
BE904030A (fr) Procede de recherche d'anticorps et equipement ou kit pour la mise en oeuvre de ce procede.
ES2072883T3 (es) Inmunoensayo de una etapa para la determinacion de anticuerpos especificos de antigenos de todas las clases de inmunoglobulinas y agente adecuado para ello.
ES2060634T3 (es) Procedimiento para la busqueda e identificacion de anticuerpos eritrociarios con la ayuda del metodo de fases solidas.
AU618137B2 (en) Process for the determination of antibodies which are class-specific for an antigen and a reagent for carrying out the process
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
DE3854834D1 (de) Immuntest unter Verwendung von Antigenen, produziert in heterologen Organismen
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
Spalding et al. [8] Antiisotypic antibodies
EP0186371A3 (en) Monoclonal antibodies specific to antigens of hepatitis b virus
ES2029890T3 (es) Inmunoensayo.
ES2094115T3 (es) Inmunoensayo.
Portetelle et al. Competition enzyme-linked immunosorbent assay(ELISA) for the diagnosis of bovine leukemia virus infection.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 372217

Country of ref document: ES